227 related articles for article (PubMed ID: 26372838)
1. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Younus M; Mo J; Yan J; Ussetti P; Chin-Hong PV; Solé A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Aram J; Singer LG; Husain S
Am J Transplant; 2018 Jan; 18(1):113-124. PubMed ID: 28898527
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
Tang H; Shi W; Song Y; Han J
J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
[TBL] [Abstract][Full Text] [Related]
5. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
[TBL] [Abstract][Full Text] [Related]
6. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.
Kolaitis NA; Duffy E; Zhang A; Lo M; Barba DT; Chen M; Soriano T; Hu J; Nabili V; Saggar R; Sayah DM; DerHovanessian A; Shino MY; Lynch JP; Kubak BM; Ardehali A; Ross DJ; Belperio JA; Elashoff D; Saggar R; Weigt SS
Transpl Int; 2017 Jan; 30(1):41-48. PubMed ID: 27678492
[TBL] [Abstract][Full Text] [Related]
9. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
11. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
[No Abstract] [Full Text] [Related]
12. 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.
Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Ussetti P; Solé J; Gavaldá J; Roman A
Transpl Int; 2016 Jan; 29(1):51-62. PubMed ID: 26339864
[TBL] [Abstract][Full Text] [Related]
13. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.
Salmeron G; Porcher R; Bergeron A; Robin M; Peffault de Latour R; Ferry C; Rocha V; Petropoulou A; Xhaard A; Lacroix C; Sulahian A; Socié G; Ribaud P
Haematologica; 2012 Sep; 97(9):1357-63. PubMed ID: 22371177
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment.
Wong JY; Kuzel P; Mullen J; Lien D; Mahmood M; Conrad C; Fiorillo L
Pediatr Transplant; 2014 Sep; 18(6):E200-7. PubMed ID: 25039541
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.
Williams K; Mansh M; Chin-Hong P; Singer J; Arron ST
Clin Infect Dis; 2014 Apr; 58(7):997-1002. PubMed ID: 24363331
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
[TBL] [Abstract][Full Text] [Related]
17. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant.
Hosseini-Moghaddam SM; Chaparro C; Luong ML; Azad S; Singer LG; Mazzulli T; Rotstein C; Keshavjee S; Husain S
Transplantation; 2015 Nov; 99(11):2387-93. PubMed ID: 25961491
[TBL] [Abstract][Full Text] [Related]
19. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of the risk factors for developing aspergillosis following cardiac transplant.
Cook JC; Cook A; Tran RH; Chang PP; Rodgers JE
Clin Transplant; 2018 Sep; 32(9):e13367. PubMed ID: 30074643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]